![](/images/general/no_picture/200_user.png)
Hai V Tran
Examiner (ID: 9064, Phone: (571)270-7650 , Office: P/2845 )
Most Active Art Unit | 2845 |
Art Unit(s) | 2611, 2845, 2426, 4100, 2711, 2623, 2423, 2491, 2821 |
Total Applications | 1291 |
Issued Applications | 923 |
Pending Applications | 111 |
Abandoned Applications | 257 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11668482
[patent_doc_number] => 20170157202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION'
[patent_app_type] => utility
[patent_app_number] => 15/426693
[patent_app_country] => US
[patent_app_date] => 2017-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 51941
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15426693
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/426693 | Vasopressin formulations for use in treatment of hypotension | Feb 6, 2017 | Issued |
Array
(
[id] => 13793315
[patent_doc_number] => 20190010196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => UBIQUITIN VARIANTS AND USES THEROF AS 53BP1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/073501
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073501
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073501 | Ubiquitin variants and uses therof as 53BP1 inhibitors | Jan 30, 2017 | Issued |
Array
(
[id] => 11602552
[patent_doc_number] => 20170119853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'Cardio-Metabolic and Vascular Effects of GLP-1 Metabolites'
[patent_app_type] => utility
[patent_app_number] => 15/407904
[patent_app_country] => US
[patent_app_date] => 2017-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14452
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15407904
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/407904 | Cardio-Metabolic and Vascular Effects of GLP-1 Metabolites | Jan 16, 2017 | Abandoned |
Array
(
[id] => 15912767
[patent_doc_number] => 10653603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => N-acyldipeptide derivatives and their uses
[patent_app_type] => utility
[patent_app_number] => 15/407474
[patent_app_country] => US
[patent_app_date] => 2017-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17983
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15407474
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/407474 | N-acyldipeptide derivatives and their uses | Jan 16, 2017 | Issued |
Array
(
[id] => 11619738
[patent_doc_number] => 20170129925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'PROCESS OF PREPARING GUANYLATE CYCLASE C AGONISYS'
[patent_app_type] => utility
[patent_app_number] => 15/405787
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 43490
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15405787
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/405787 | Process of preparing guanylate cyclase C agonisys | Jan 12, 2017 | Issued |
Array
(
[id] => 11604082
[patent_doc_number] => 20170121383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'THERAPEUTIC USE OF BONE MORPHOGENETIC PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/404265
[patent_app_country] => US
[patent_app_date] => 2017-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10817
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15404265
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/404265 | THERAPEUTIC USE OF BONE MORPHOGENETIC PROTEINS | Jan 11, 2017 | Abandoned |
Array
(
[id] => 17005486
[patent_doc_number] => 20210236647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => PEPTIDE-CONJUGATED NANOPARTICLES FOR TARGETING, IMAGING, AND TREATMENT OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/062274
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062274
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062274 | Peptide-conjugated nanoparticles for targeting, imaging, and treatment of prostate cancer | Jan 10, 2017 | Issued |
Array
(
[id] => 15913045
[patent_doc_number] => 10653744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Formulations and methods for treating ulcerative colitis
[patent_app_type] => utility
[patent_app_number] => 16/069313
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13211
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069313
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069313 | Formulations and methods for treating ulcerative colitis | Jan 10, 2017 | Issued |
Array
(
[id] => 13548933
[patent_doc_number] => 20180326014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF DIABETES
[patent_app_type] => utility
[patent_app_number] => 16/069039
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069039
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069039 | PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF DIABETES | Jan 10, 2017 | Abandoned |
Array
(
[id] => 11713618
[patent_doc_number] => 20170182118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'PREPARATIONS CONTAINING AMORPHOUS EMODEPSIDE'
[patent_app_type] => utility
[patent_app_number] => 15/397923
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3386
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15397923
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/397923 | PREPARATIONS CONTAINING AMORPHOUS EMODEPSIDE | Jan 3, 2017 | Abandoned |
Array
(
[id] => 17118298
[patent_doc_number] => 11129404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-28
[patent_title] => Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/066585
[patent_app_country] => US
[patent_app_date] => 2016-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10761
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16066585
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/066585 | Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof | Dec 26, 2016 | Issued |
Array
(
[id] => 15267445
[patent_doc_number] => 20190382456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => STAPLED PEPTIDE INHIBITORS OF NEMO AS POTENTIAL ANTI-INFLAMMATORY AND ANTI-CANCER DRUGS
[patent_app_type] => utility
[patent_app_number] => 15/776481
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15776481
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/776481 | Stapled peptide inhibitors of NEMO as potential anti-inflammatory and anti-cancer drugs | Dec 21, 2016 | Issued |
Array
(
[id] => 11713526
[patent_doc_number] => 20170182025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/385763
[patent_app_country] => US
[patent_app_date] => 2016-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 44096
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15385763
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/385763 | BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY | Dec 19, 2016 | Abandoned |
Array
(
[id] => 15117167
[patent_doc_number] => 20190345216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => SorCS PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/061085
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061085
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061085 | SorCS PEPTIDES AND USES THEREOF | Dec 18, 2016 | Abandoned |
Array
(
[id] => 14072331
[patent_doc_number] => 20190085053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS
[patent_app_type] => utility
[patent_app_number] => 16/063437
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063437
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063437 | Synthetic lung surfactant with enhanced stability and effectiveness | Dec 15, 2016 | Issued |
Array
(
[id] => 11527240
[patent_doc_number] => 20170087217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'SUPERIOR CONTROL OF BLOOD GLUCOSE IN DIABETES TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/377641
[patent_app_country] => US
[patent_app_date] => 2016-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 17646
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15377641
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/377641 | SUPERIOR CONTROL OF BLOOD GLUCOSE IN DIABETES TREATMENT | Dec 12, 2016 | Abandoned |
Array
(
[id] => 13885433
[patent_doc_number] => 10195248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-05
[patent_title] => Use of haptoglobin subunit for promoting wound healing
[patent_app_type] => utility
[patent_app_number] => 15/371233
[patent_app_country] => US
[patent_app_date] => 2016-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 1560
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15371233
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/371233 | Use of haptoglobin subunit for promoting wound healing | Dec 6, 2016 | Issued |
Array
(
[id] => 13853987
[patent_doc_number] => 10188700
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Use of haptoglobin subunit for promoting angiogenesis
[patent_app_type] => utility
[patent_app_number] => 15/371231
[patent_app_country] => US
[patent_app_date] => 2016-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1963
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15371231
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/371231 | Use of haptoglobin subunit for promoting angiogenesis | Dec 6, 2016 | Issued |
Array
(
[id] => 12001812
[patent_doc_number] => 20170305967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'METHODS FOR REDUCING CD36 EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 15/369281
[patent_app_country] => US
[patent_app_date] => 2016-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11307
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15369281
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/369281 | METHODS FOR REDUCING CD36 EXPRESSION | Dec 4, 2016 | Abandoned |
Array
(
[id] => 16369081
[patent_doc_number] => 10800822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-13
[patent_title] => Histatins and method of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/775901
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 8524
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775901
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/775901 | Histatins and method of use thereof | Nov 28, 2016 | Issued |